Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.63	36.06	41.87	61.33	133.58
Short-Term Investments	157.03	243.01	273.31	374.89	482.33
Cash & Short-Term Investments	203.66	279.07	315.18	436.23	615.91
Cash Growth	-27.02%	-11.46%	-27.75%	-29.17%	27.54%
Accounts Receivable	0.92	3.54	1.83	38.48	8.68
Other Receivables	-	2.1	0.9	0.8	1.1
Receivables	0.92	5.64	2.73	39.28	9.78
Prepaid Expenses	4.13	7.2	13.64	26.57	7.73
Total Current Assets	208.7	291.91	331.54	502.07	633.41
Property, Plant & Equipment	98.53	110.89	158.51	176.09	162.25
Long-Term Investments	1.47	27.66	0.98	4.94	100.66
Long-Term Deferred Charges	-	-	-	7.2	9.87
Other Long-Term Assets	10.23	10.24	15.19	15.26	15.26
Total Assets	318.94	440.69	506.22	705.56	921.46
Accounts Payable	2.66	9.37	4.72	8.27	8.61
Accrued Expenses	20.02	21.35	27.51	53.93	42.41
Current Portion of Leases	4.56	7.42	6.18	5.63	5.58
Current Unearned Revenue	0.38	0.39	0.69	42.23	21.48
Other Current Liabilities	8.45	-	-	4	3.2
Total Current Liabilities	36.07	38.52	39.09	114.05	81.28
Long-Term Leases	73.29	77.85	97.36	103.71	109.24
Long-Term Unearned Revenue	-	-	-	-	27.12
Other Long-Term Liabilities	2.4	5.6	1.35	3.86	24.97
Total Liabilities	111.75	121.97	137.8	221.62	242.62
Common Stock	0.12	0.11	0.1	0.1	0.1
Additional Paid-In Capital	1,741	1,716	1,580	1,536	1,449
Retained Earnings	-1,534	-1,398	-1,212	-1,051	-769.08
Comprehensive Income & Other	0.12	0.27	0.02	-1.85	-0.76
Total Common Equity	207.18	318.72	368.41	483.94	678.84
Shareholders' Equity	207.18	318.73	368.42	483.94	678.84
Total Liabilities & Equity	318.94	440.69	506.22	705.56	921.46
Total Debt	77.85	85.27	103.54	109.34	114.82
Net Cash (Debt)	125.81	193.8	211.64	326.89	501.09
Net Cash Growth	-35.09%	-8.43%	-35.26%	-34.77%	29.95%
Net Cash Per Share	1.06	1.70	2.15	3.38	5.29
Filing Date Shares Outstanding	116.26	114.6	99.24	98.16	96.43
Total Common Shares Outstanding	115.36	113.93	98.63	97.29	95.73
Working Capital	172.63	253.39	292.45	388.02	552.13
Book Value Per Share	1.80	2.80	3.74	4.97	7.09
Tangible Book Value	207.18	318.72	368.41	483.94	678.84
Tangible Book Value Per Share	1.80	2.80	3.74	4.97	7.09
Machinery	-	38.85	83.29	81.5	53.63
Leasehold Improvements	-	59.49	59.04	56.78	52.95

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q